Free Trial

Genus Final Earnings Report

Genus logo
GBX 1,889.33 -0.67 (-0.04%)
As of 08:20 AM Eastern

Genus EPS Results

Actual EPS
GBX 39.80
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Genus Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Genus Announcement Details

Quarter
Final
Time
Before Market Opens

Conference Call Resources

Genus Earnings Headlines

Kepler Capital Keeps Their Buy Rating on Genus plc (GNS)
Must-See: Trump’s Shocking AI Announcement
If you have any investments in AI stocks or are interested in AI… Please take a moment to review the details about a shocking AI announcement President Trump made in the White House.
See More Genus Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Genus? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Genus and other key companies, straight to your email.

About Genus

Genus (LON:GNS) operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

View Genus Profile

More Earnings Resources from MarketBeat